These findings suggest that CD271+ PSCs may play a defensive role in pancreatic carcinogenesis and/or progression of pancreatic cancer, and that long-term interactions with cancer cells may reduce the number of CD271+ PSCs. This evidence concerns the gene NGFR and cancer.